Loading publications…
The last 5 uploaded publications
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
Mohsen Malehmir, Dominik Pfister, Suchira Gallage, Marta Szydlowska, Donato Inverso, Elena Kotsiliti, Valentina Leone, Moritz Peiseler, Bas G. J. Surewaard, Dominik Rath, Adnan Ali, Monika Wolf, Hannah K. Drescher, Marc E. Healy, Daniel Dauch, Daniela C. Kroy, Oliver Krenkel, Marlene Kohlhepp, Thomas Engleitner, Alexander Olkus, Tjeerd Sijmonsma, Julia Volz, Carsten Deppermann, David Stegner, Patrick M. Helbling, César Nombela‐Arrieta, Anahita Rafiei, Martina Hinterleitner, Marcel Rall, Florian Baku, Oliver Borst, Caroline Wilson, Jack Leslie, Tracy O’Connor, Chris J. Weston, Abhishek Chauhan, David H. Adams, Lozan Sheriff, Ana Teijeiro, Marco Prinz, Ruzhica Bogeska, Natasha S. Anstee, Malte N. Bongers, Mike Notohamiprodjo, Tobias Geisler, Dominic J. Withers, Jerry Ware, Derek A. Mann, Hellmut G. Augustin, Alexandros Vegiopoulos, Michael D. Milsom, Adam J. Rose, Patricia F. Lalor, Josep M. Llovet, Roser Pinyol, Frank Tacke, Roland Rad, Matthias S. Matter, Nabil Djouder, Paul Kubes, Percy A. Knolle, Kristian Unger, Lars Zender, Bernhard Nieswandt, Meinrad Gawaz, Achim Weber, Mathias Heikenwälder (2019). Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer. Nature Medicine, 25(4), pp. 641-655, DOI: 10.1038/s41591-019-0379-5.
Article145 days agoIGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models
Iris Martinez-Quetglas, Roser Pinyol, Daniel Dauch, Sara Torrecilla, Victoria Tovar, Agrin Moeini, Clara Alsinet, Anna Portela, Leonardo Rodríguez‐Carunchio, Manel Solé, Amaia Lujambio, Augusto Villanueva, Swan N. Thung, Manel Esteller, Lars Zender, Josep M. Llovet (2016). IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models. Gastroenterology, 151(6), pp. 1192-1205, DOI: 10.1053/j.gastro.2016.09.001.
Article145 days ago466 IGF2 drives IGF oncogenic signaling in HCC and emerges as a potential target for therapies
I.M. Quetglas, Roser Pinyol, Daniel Dauch, Anna Portela, Alberto Villanueva, Judit Peix, María Ángeles Moreno de la Higuera, Agrin Moeini, Jessica Zucman‐Rossi, Manel Esteller, Vincenzo Mazzaferro, Lars Zender, Josep M. Llovet (2014). 466 IGF2 drives IGF oncogenic signaling in HCC and emerges as a potential target for therapies. European Journal of Cancer, 50, pp. 152-152, DOI: 10.1016/s0959-8049(14)70592-1.
Article145 days agoP0265 : IGF2 is an oncogenic driver in HCC and emerges as a potential target for therapies
Iris Martinez-Quetglas, Roser Pinyol, Daniel Dauch, Anna Portela, Judit Peix, Mónica Higuera, Jessica Zucman‐Rossi, Manel Esteller, Vincenzo Mazzaferro, Lars Zender, Josep M. Llovet (2015). P0265 : IGF2 is an oncogenic driver in HCC and emerges as a potential target for therapies. Journal of Hepatology, 62, pp. S405-S406, DOI: 10.1016/s0168-8278(15)30481-5.
Article145 days agoAbstract 3820: Epigenetic re-expression of fetal IGF2 as therapeutic target in hepatocellular carcinoma
Iris Martinez-Quetglas, Roser Pinyol, Daniel Dauch, Sara Torrecilla, Victoria Tovar, Agrin Moeini, Clara Alsinet, Anna Portela, Augusto Villanueva, Manel Esteller, Lars Zender, Josep M. Llovet (2016). Abstract 3820: Epigenetic re-expression of fetal IGF2 as therapeutic target in hepatocellular carcinoma. Cancer Research, 76(14_Supplement), pp. 3820-3820, DOI: 10.1158/1538-7445.am2016-3820.
Article145 days ago